Aethlon Medical, Inc.
NCM: AEMDLive Quote
About Aethlon Medical, Inc.
Healthcare
Medical Devices
Aethlon Medical, Inc., a medical therapeutic company, engages in developing novel immunotherapeutic devices to treat cancer and viral infections in the United States. It develops Hemopurifier, a clinical-stage immunotherapeutic device intended for applications in cancer, and life-threatening viral infections, and use in organ transplantation. The company was founded in 1984 and is based in San Diego, California.
📊 Fundamental Analysis
Aethlon Medical, Inc. demonstrates a profit margin of 0.0%, which is below the sector average, suggesting competitive pressure.
Return on Equity (ROE) is -208.6%, which indicates that capital utilization is currently under pressure.
At a current price of $2.17, AEMD currently trades near the bottom of its 52-week range (2%), indicating potential value or weakness (Range: $1.36 - $35.20).
🏥 Financial Health
🔴
Profit Margin
Weak
✅
Debt/Equity
Excellent
🔴
Return on Equity
Weak
🔴
Beta (Risk)
High Volatility
Key Financials
Market Cap
$3.04M
Trailing P/E
--
Forward P/E
-2.21
Beta (5Y)
1.52
52W High
$35.20
52W Low
$1.36
Avg Volume
55K
Day High
Day Low
📡 Subscribe to ZcoreAI updates
Join the list to get access to:
- Z-Score signals at market open
- New app features and updates
- Exclusive promo for ZcoreAI App